|Co-solvent free||No need to dissolve lipids or hydrophobic compounds in a co-solvent. All the materials can be included in the aqueous buffer, and then formulated.|
|Low-Temperature Formulation||Liposomes can be formed at 4°C, irrespective of the lipid phase transition temperature.|
|Delicate Compounds||Energy levels can be pre-set to enable formulation of delicate macromolecules such as siRNA and proteins.|
|Short Processing Time||One-step formulation using an automated apparatus.|
|No Cross Contamination||Liposomes are produced in single-use autoclavable vessels.|
|Automated Size Control (under development)||Real-time monitoring and feedback control of particle size.|
|Scalable||Capable of scaling from 100 µL to continuous flow manufacturing.|
Covaris provides tools and technologies to improve pre-analytical sample preparation, enable novel drug formulations, and manage compounds in the drug discovery process.